United States · 
Who invested in Sapience Therapeutics?
Sapience Therapeutics's investors include National Institute of Allergy and Infectious Diseases.
United States · Funded startup
Who invested in Sapience Therapeutics
Funding summaryUpdated 26 Oct 2026
$2.0Mraised across 1 round since 2023, from 1 source
- Latest round
- Grant, $2.0MMay 2023
- Investors
- 1
The rounds
- May 2023
Founders and team
From the SEC filings it signed: 1 on the team.
- Barry KappelExecutive Officer, Directori
On the board, as filediChristian SchadeDavid ScheinbergHoward PienRobert Ruffolo
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
These 2 firms list Sapience Therapeutics as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Sapience Therapeutics
How much has Sapience Therapeutics raised?
Sapience Therapeutics has raised $2.0M across 1 round since 2023.
When did Sapience Therapeutics last raise?
Sapience Therapeutics's most recent round was a Grant of $2.0M in May 2023.
What was Sapience Therapeutics's biggest round?
Its most recent round, $2.0M in May 2023, is also its largest on record.
Who backed Sapience Therapeutics first?
Sapience Therapeutics's first round on record, in May 2023, was backed by National Institute of Allergy and Infectious Diseases.
What stage is Sapience Therapeutics at?
Sapience Therapeutics's latest named round is a Grant, in May 2023.
Where is Sapience Therapeutics based?
Sapience Therapeutics is based in the United States.
Companies like Sapience Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.